Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pSer290) Peptide
MAP3K8
Reactivity: Human, Mouse, Rat, Cow, Monkey
Host: Synthetic
BP
-
- Target See all MAP3K8 products
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
- Protein Region
- pSer290
- Origin
- Human, Mouse, Rat, Cow, Monkey
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-TPL2 (pT290) Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
- Synonyms
- MAP3K8 Peptide, COT Peptide, EST Peptide, ESTF Peptide, MEKK8 Peptide, TPL2 Peptide, Tpl-2 Peptide, c-COT Peptide, Cot Peptide, Cot/Tpl2 Peptide, Est Peptide, Estf Peptide, Tpl2 Peptide, D17TPL2 Peptide, mitogen-activated protein kinase kinase kinase 8 Peptide, MAP3K8 Peptide, map3k8 Peptide, Map3k8 Peptide
- Background
- COT, ESTF, Mitogen-activated protein kinase kinase kinase 8, Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, Serine/threonine-protein kinase cot, Tumor progression locus 2, TPL-2
- Gene ID
- 1326, 26410, 116596
- UniProt
- P41279, Q07174, Q63562
-
You are here:
